Publicaciones (42) Publicaciones de Miguel Ángel García González

2024

  1. Gene editing: a near future for the treatment of genetic kidney diseases

    Kidney International

2023

  1. Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  2. Genetic testing in focal segmental glomerulosclerosis: in whom and when?

    Clinical Kidney Journal, Vol. 16, Núm. 11, pp. 2011-2022

  3. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge

    Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205

2022

  1. Genetic Kidney Diseases (GKDs) Modeling Using Genome Editing Technologies

    Cells, Vol. 11, Núm. 9

  2. Long-term outcome of omalizumab-assisted desensitisation to cow's milk and eggs in patients refractory to conventional oral immunotherapy: real-life study

    Allergologia et Immunopathologia, Vol. 50, Núm. 3, pp. 1-7

  3. Quantitative Proteomic Study Unmasks Fibrinogen Pathway in Polycystic Liver Disease

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Molecular basis, diagnostic challenges and therapeutic approaches of alport syndrome: A primer for clinicians

    International Journal of Molecular Sciences, Vol. 22, Núm. 20

  2. Molecular basis, diagnostic challenges and therapeutic approaches of bartter and gitelman syndromes: A primer for clinicians

    International Journal of Molecular Sciences, Vol. 22, Núm. 21

  3. Molecular pathophysiology of autosomal recessive polycystic kidney disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  4. Protein Extraction From FFPE Kidney Tissue Samples: A Review of the Literature and Characterization of Techniques

    Frontiers in Medicine, Vol. 8

  5. Tweak signaling pathway blockade slows cyst growth and disease progression in autosomal dominant polycystic kidney disease

    Journal of the American Society of Nephrology, Vol. 32, Núm. 8, pp. 1913-1932

2020

  1. Association of single nucleotide polymorphisms with renal cell carcinoma in Algerian population

    African Journal of Urology, Vol. 26, Núm. 1

  2. CystAnalyser: A new software tool for the automatic detection and quantification of cysts in polycystic kidney and liver disease, and other cystic disorders

    PLoS Computational Biology, Vol. 16, Núm. 10

  3. First-Days Reduction of Plasma and Skin Advanced Glycation End Products is Related to Outcome in Septic Patients

    Shock, Vol. 53, Núm. 4, pp. 400-406

2019

  1. Dietary care for ADPKD patients: Current status and future directions

    Nutrients, Vol. 11, Núm. 7

2018

  1. Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1

    American Journal of Kidney Diseases, Vol. 72, Núm. 3, pp. 411-418

  2. Overview of autosomal dominant polycystic kidney disease in the south of Spain

    Nefrologia, Vol. 38, Núm. 2, pp. 220-221

  3. Pkd2 deletion during embryo development does not alter mesonephric programmed cell senescence

    International Journal of Developmental Biology, Vol. 62, Núm. 9-10, pp. 637-640

2017

  1. NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology

    Scientific Reports, Vol. 7, Núm. 1